相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
Kirsten Fischer et al.
BLOOD (2016)
Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages
A. K. Church et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome
Giuseppe Carli et al.
ANNALS OF HEMATOLOGY (2016)
Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis
Sameer A. Parikh et al.
BLOOD (2016)
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Benjamin L. Lampson et al.
BLOOD (2016)
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib
Candida Vitale et al.
HAEMATOLOGICA (2016)
Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy
Stefano Molica et al.
LEUKEMIA RESEARCH (2016)
Secondary autoimmune cytopenias in chronic lymphocytic leukemia
Kerry A. Rogers et al.
SEMINARS IN ONCOLOGY (2016)
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib
Candida Vitale et al.
HAEMATOLOGICA (2016)
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)
Anne Quinquenel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes
Sameer A. Parikh et al.
CANCER (2015)
Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias
Deepesh P. Lad et al.
LEUKEMIA & LYMPHOMA (2015)
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
J. A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
An interactive reference framework for modeling a dynamic immune system
Matthew H. Spitzer et al.
SCIENCE (2015)
Old DAT and new data: Positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients
Anne Quinquenel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Autoimmune cytopenias in chronic lymphocytic leukemia
Carlo Visco et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia
E. Jolliffe et al.
INTERNAL MEDICINE JOURNAL (2014)
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
Carlo Visco et al.
LEUKEMIA & LYMPHOMA (2014)
Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression
Wilma Barcellini et al.
LEUKEMIA & LYMPHOMA (2014)
Ibrutinib Resistance in Chronic Lymphocytic Leukemia
Richard R. Furman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Richard R. Furman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Intravenous Immunoglobulin Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection: A Retrospective Study of 10 Patients and Review of the Literature
Yoann Crabol et al.
CLINICAL INFECTIOUS DISEASES (2013)
Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in seven cases of Chinese children
Lu-Hong Xu et al.
HEMATOLOGY (2013)
Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia
Dimitrios P. Kontoyiannis et al.
LEUKEMIA & LYMPHOMA (2013)
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia
Gianluigi Reda et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Wilma Barcellini et al.
BLOOD (2012)
A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
Paolo Strati et al.
CURRENT OPINION IN ONCOLOGY (2011)
Chronic lymphocytic leukemia and autoimmunity: a systematic review
Kate Hodgson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia
J. Rossignol et al.
LEUKEMIA (2011)
Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia
Anne-Sophie Michallet et al.
LEUKEMIA & LYMPHOMA (2011)
Autoimmune Complications in Chronic Lymphocytic Leukaemia (CLL)
Clive S. Zent et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance
Carol Moreno et al.
BLOOD (2010)
Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP
S. Koehrer et al.
LEUKEMIA (2010)
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone
Deborah A. Bowen et al.
LEUKEMIA & LYMPHOMA (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
T-cell function in chronic lymphocytic leukaemia
John C. Riches et al.
SEMINARS IN CANCER BIOLOGY (2010)
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases
Marc Michel et al.
BLOOD (2009)
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
James B. Bussel et al.
LANCET (2009)
A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia
Matthew Kaufman et al.
LEUKEMIA & LYMPHOMA (2009)
Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis
Clive S. Zent et al.
LEUKEMIA & LYMPHOMA (2009)
Just exactly how common is CLL?
Terry J. Hamblin
LEUKEMIA RESEARCH (2009)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
Michael Hallek et al.
BLOOD (2008)
Acquired pure red cell aplasia: updated review of treatment
Kenichi Sawada et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma
Clive S. Zent et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia
Claire Dearden et al.
BLOOD (2008)
Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient
Massimo Gentile et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody)
C. Karlsson et al.
LEUKEMIA (2007)
Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab - incidence and predictors
Gautam Borthakur et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia
Gulsum Emel Pamuk et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
Giovanni D'Arena et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: Report of two cases and review of the literature
K Narra et al.
LEUKEMIA RESEARCH (2006)
Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells
AM Hall et al.
BLOOD (2005)
Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma
MJ Kyasa et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia
W Barcellini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia
N Gupta et al.
LEUKEMIA (2002)